Excelsior Biopharma Inc. (6496.TWO)

TWD 26.9

(-1.65%)

Operating Expenses Summary of Excelsior Biopharma Inc.

  • Excelsior Biopharma Inc.'s latest annual operating expenses in 2023 was 388.05 Million TWD , up 20.91% from previous year.
  • Excelsior Biopharma Inc.'s latest quarterly operating expenses in 2024 Q2 was 115.7 Million TWD , down -13.43% from previous quarter.
  • Excelsior Biopharma Inc. reported a annual operating expenses of 320.13 Million TWD in annual operating expenses 2022, up 7.55% from previous year.
  • Excelsior Biopharma Inc. reported a annual operating expenses of 297.64 Million TWD in annual operating expenses 2021, up 10.54% from previous year.
  • Excelsior Biopharma Inc. reported a quarterly operating expenses of 113.64 Million TWD for 2024 Q1, up 24.81% from previous quarter.
  • Excelsior Biopharma Inc. reported a quarterly operating expenses of 91.05 Million TWD for 2023 Q4, down -14.63% from previous quarter.

Annual Operating Expenses Chart of Excelsior Biopharma Inc. (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Expenses20192019.520202020.520212021.520222022.52023250000000 TWD300000000 TWD350000000 TWD400000000 TWD

Historical Annual Operating Expenses of Excelsior Biopharma Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 388.05 Million TWD 20.91%
2022 320.13 Million TWD 7.55%
2021 297.64 Million TWD 10.54%
2020 269.26 Million TWD 0.92%
2019 266.8 Million TWD 0.0%

Peer Operating Expenses Comparison of Excelsior Biopharma Inc.

Name Operating Expenses Operating Expenses Difference
Allied Biotech Corporation 157.72 Million TWD -146.035%
GeneFerm Biotechnology Co., Ltd. 132.78 Million TWD -192.243%
Easywell Biomedicals, Inc. 333.45 Million TWD -16.375%
TTY Biopharm Company Limited 1.91 Billion TWD 79.7%
Synmosa Biopharma Corporation 1.49 Billion TWD 74.122%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 81.927%
Center Laboratories, Inc. 697.35 Million TWD 44.353%
Tien Liang BioTech Co., Ltd. 267.27 Million TWD -45.191%
Orient Pharma Co., Ltd. 468.66 Million TWD 17.2%
InnoPharmax Inc. 82.29 Million TWD -371.539%
Johnson Chemical Pharmaceutical Works Co., Ltd. 244.63 Million TWD -58.629%
DV Biomed Co., Ltd. 575.24 Million TWD 32.54%
Foresee Pharmaceuticals Co., Ltd. 1.12 Billion TWD 65.401%
Handa Pharmaceuticals, Inc. 399.14 Million TWD 2.779%
UniPharma Co., Ltd. 78.32 Million TWD -395.471%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 2.236%
Alar Pharmaceuticals Inc. 83.74 Million TWD -363.381%
Winston Medical Supply Co., Ltd. 151.49 Million TWD -156.149%
Mercury Biopharmaceutical Corporation 592 Thousand TWD -65450.338%
Bioray Biotech Co., Ltd 96.98 Million TWD -300.134%
TSH Biopharm Corporation Limited 336.26 Million TWD -15.401%